AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®

Data ReadoutpositiveABP-450BOTOXPositive

AI Analysis

Summary

AEON reported expanded structural characterization data for ABP-450, a botulinum neurotoxin biosimilar candidate, demonstrating 98% coverage of the primary sequence with 100% amino acid identity to BOTOX across all analyzed regions.

Outcome Details

Expanded structural data supporting molecular similarity to reference product; peptide-mapping coverage increased from 93% to 98% with 100% amino acid identity across analyzed regions

Importance:5/10

Sentiment:

0.60

biosimilarstructural_analysisbotulinum_neurotoxinanalytical_data

Related Companies

$MOLN $ACTI.ST

Read the original article

Published by GlobeNewswire Clinical Studies on August 19, 2026 12:00 PM

Read Original